Erectile Dysfunction Archive
Original research on Indian patients by Dr.SS.Vasan, President-Elect, SASSM | Li-ESWT for ED The Canadian Journal of Urology™; 22(1); February 2015 Get the full article here.
Natesto: Nasal testosterone gel | For young men with low T! End points: * The primary endpoint will be the change in FSH, LH, Estradiol, T, and Semen Analysis after 12 weeks and 24 weeks of treatment with Natesto. * The secondary endpoint will be monitoring for adverse events. Read more details on trial results here.
Efficacy and Safety of MED2005, a Topical Glyceryl Trinitrate Formulation, in the Treatment of Erectile Dysfunction: A Randomized Crossover Study. “For all assessments, significant effects of MED2005 were seen primarily in patients with mild ED. The start of erection was noticed within 5 and 10 minutes in 44.2% and 69.5%, respectively, of all intercourse, attempts
Methods to reverse Erectile Dysfunction: Check it out from here.
REVACTIN | New neutraceutical targeting iNOS and thereby improving Erectile Function, Orgasmic Function, Sexual Desire, Intercourse Satisfaction & Overall Satisfaction. Longterm/Longitudinal studies are further needed to ascertain it’s safety & efficiency. Read more about the role of iNOS here. Disclaimer: SASSM doesn’t endorse REVACTIN.
PDE5 inhibitors are safe drugs for the management of ED. Although recent studies have shown an increased risk of non-arteritic ischemic optic neuropathy with PDE5Is, the magnitude of that risk is small. The possibility that PDE5Is cause sensorineural hearing loss remains uncertain. Read more about it here.
Penile Prosthesis Implantation is the most effective treatment for post-priapism ED and can be performed immediately or delayed. https://doi.org/10.1016/j.sxmr.2017.08.002
Deciding Which Testosterone Therapy to Prescribe DOI: https://doi.org/10.1016/j.jsxm.2018.02.006
Read about venous leakage from our parent body, ISSM here.
Men’s Health Magazine has written a great blog on the drugs for ED for a common person understanding Read more about it here.